Home » Stocks » CANB

Can B Corp (CANB)

Stock Price: $0.4200 USD 0.0100 (2.44%)
Updated May 12, 2021 2:18 PM EDT - Market closed
Market Cap 7.00M
Revenue (ttm) 1.71M
Net Income (ttm) -5.72M
Shares Out 3.53M
EPS (ttm) -1.62
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 12
Last Price $0.4200
Previous Close $0.4100
Change ($) 0.0100
Change (%) 2.44%
Day's Open 0.4100
Day's Range 0.4100 - 0.4500
Day's Volume 12,136
52-Week Range 0.3500 - 2.1100


Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

HICKSVILLE, NY / ACCESSWIRE / May 12, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a diversified health and wellness company, is pleased to announce its recent purchases of additional equ...

1 day ago - Accesswire

Strong Gross Margin of 84%  Efficiencies and Lower Expenses Lead to a Significant Reduction in Operating Loss HICKSVILLE, NY /  ACCESSWIRE /  April 14, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "C...

4 weeks ago - Accesswire

CEO Marco Alfonsi to Highlight the Company's CBD Branded Products and Diverse Sales Channel Strategy HICKSVILLE, NY / ACCESSWIRE / March 22, 2021 / Can B Corp. (OTCQB: CANB) ("Can B" or the "Company"), ...

1 month ago - Accesswire

Adds Expertise in Pharmacokinetics for the Confluence of Science, Nature, and Culture HICKSVILLE, NY / ACCESSWIRE / March 18, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a diversified he...

1 month ago - Accesswire

Targeting Spas, Salons and High-End Retailers

2 months ago - GlobeNewsWire

Expanded Manufacturing Capacity to Lead to Several Additional Revenue Opportunities

2 months ago - GlobeNewsWire

Targeting Medical Professionals and Direct-to-Consumer Sales Channels to Proactively Optimize Immune Systems

3 months ago - GlobeNewsWire

Well-Positioned with Diversified Products and Multi-Channel Distribution for Growth in 2021

3 months ago - GlobeNewsWire

About CANB

Can B Corp. produces and sells cannabidiol (CBD) based products in the United States. It provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, and concentrates through its Website and vending machines, and other medical professionals. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in February 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.

Drug Manufacturers-Specialty & Generic
Marco Alfonsi
Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

In 2020, Can B Corp's revenue was $1.71 million, a decrease of -25.84% compared to the previous year's $2.31 million. Losses were -$5.72 million, -3.12% less than in 2019.

Financial Statements